LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹0.73 Cr | ₹0.10 Cr | ₹25 Cr | - | ₹16 Cr |
What is the latest Long Term Provisions ratio of LINCOLN PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹0.73 Cr |
| Mar2024 | ₹0.10 Cr |
| Mar2023 | ₹25 Cr |
| Mar2022 | - |
| Mar2021 | ₹16 Cr |
How is Long Term Provisions of LINCOLN PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.73 Cr | 656.70 | |
| Mar2024 | ₹0.10 Cr | -99.62 | |
| Mar2023 | ₹25 Cr | 0 | |
| Mar2022 | - | -100.00 | |
| Mar2021 | ₹16 Cr | - | |
Compare Long Term Provisions of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,219.0 Cr | 5.3% | 0.7% | 11.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 5.3% |
0.7% |
11.9% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses